The Latest Breaking News from FDA

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

Bautz: By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL APLIF RESEARCH REPORT

U.S. officials say thousands more doses of the monkeypox vaccine could soon begin shipping from Denmark

Plus: The story of a 10-year-old rape victim who sought an abortion is confirmed, inflation hits a record 9.1 percent, and more...

Here's a roundup of top developments in the biotech space over the last 24 hours:

The U.S. Preventive Services Task Force issued a recommendation statement in June 2022 on the use of over-the-counter vitamin supplements. Based on its independent panel of experts’ review of existing scientific evidence, the task force recommended against using beta carotene or vitamin E supplements for the prevention of cancer and…

CNBC United Airlines, Pilots’ Union To Improve Agreement By Renegotiating

In the nearly three weeks since the U.S. Supreme Court overturned Roe v. Wade, abortion has become illegal in at least 10 states, with more states to follow in the weeks ahead.